bluebird bio Inc (NAS:BLUE)
$ 0.405 0.0272 (7.2%) Market Cap: 78.75 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 02:30PM GMT
Release Date Price: $65.43 (-0.70%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Over the next session, just quickly before we get going, I need to read the disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk.

So I'm very pleased to have the team from bluebird here. I think you guys want to make some opening comments. I'll let you do that, and then we can jump right into it.

William D. Baird
bluebird bio, Inc. - CFO

Great. Thanks. It's great to be here today. Chip Baird, CFO for bluebird bio. My colleagues, Dave Davidson, Chief Medical Officer; and Alison Finger, our Chief Commercial Officer, are here with us as well. Pleased to be here today.

I would refer you to our safe harbor as we are prone to making forward-looking statements.

Just to introduce bluebird for those who are not familiar with the company, we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot